Kendle International Invites You To Attend Its Fourth Quarter And Year End 2005 Earnings Conference Call And Webcast

CINCINNATI, Jan. 24 /PRNewswire-FirstCall/ -- Kendle will conduct a telephone conference call and simultaneous Webcast on Feb. 14 at 8:30 a.m. Eastern Time to discuss its financial results for the Fourth Quarter and Year Ended Dec. 31, 2005. A question and answer session will follow.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO)

Webcast Instructions

To access the live Webcast, go to www.kendle.com or http://phx.corporate-ir.net/playerlink.zhtml?c=88712&s=wm&e=1200181. Instructions for accessing the Webcast are provided at both sites. The Webcast will be archived at www.kendle.com (click on "Investors") shortly after the call for on-demand replay through 5 p.m. Eastern Time on March 14. Please note that Webcast participants will not be able to ask questions.

System requirements for the Webcast include Windows Media Player software and at least a 28.8 Kbps connection to the Internet. Media Player is downloadable at no charge from http://www.microsoft.com/windows/windowsmedia/default.aspx.

Conference Call Instructions

To register (RSVP) for the telephone conference call, U.S. and Canadian participants should dial (800) 223-7104. Participants outside North America should dial (706) 645-6519.

To participate in the telephone conference call, interested parties in the United States and Canada should dial (800) 399-0069. Participants outside North America should dial (706) 643-3694. A replay will be available through 5 p.m. Eastern Time on March 14 by dialing (706) 645-9291 and entering conference ID number 4133792.

About Kendle

Kendle International Inc. is among the world's leading global clinical research organizations. We deliver innovative and robust clinical development solutions -- from first-in-human studies through market launch and surveillance -- to help the world's biopharmaceutical companies maximize product life cycles and grow market share. With the expertise of our nearly 2,000 associates worldwide, Kendle has conducted clinical trials or provided regulatory, pharmacovigilance and validation services in 70 countries. Additional information and investor kits are available upon request from Kendle, 1200 Carew Tower, 441 Vine Street, Cincinnati, OH 45202, or from the company's Web site at www.kendle.com.

Photo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comKendle International Inc.

CONTACT: Investors, Patty Frank, +1-513-763-1992, or Media, Lori Dorer,+1-513-345-1685, both for Kendle International Inc.

Web site: http://www.kendle.com/